Protocol Details
Diagnosis and Management of Inflammatory and Infectious Diseases
This study is currently recruiting participants.
Summary
Number |
78-I-0023 |
Sponsoring Institute |
National Institute of Allergy and Infectious Diseases (NIAID) |
Recruitment Detail |
Type: Participants currently recruited/enrolled
Gender: Male & Female
Min Age: 3 Years
Max Age: 100 Years |
Referral Letter Required |
No |
Population Exclusion(s) |
Fetuses;
Pregnant Women |
Keywords |
Inflammation;
Infection;
Fever;
Natural History |
Recruitment Keyword(s) |
None |
Condition(s) |
Infection;
Inflammation |
Investigational Drug(s) |
None |
Investigational Device(s) |
None |
Intervention(s) |
None |
Supporting Site |
National Institute of Allergy and Infectious Diseases |
This protocol is being established to cover the evaluation of patients with inflammatory and/or infectious diseases which are not covered under previously existing protocols. The purpose of such a protocol is that frequently patients are referred to us with either diagnosed or undiagnosed illnesses which would be of interest to our teaching program or which would serve as a source of patients to subsequently be entered into established, ongoing protocol studies. Such patients will be admitted to the protocol and handled according to accepted medical practice of diagnosis and treatment.
Eligibility
INCLUSION CRITERIA:
1. Known or suspected exposure to infection, as determined by the Principal Investigator OR Presence of signs and symptoms of an infectious or inflammatory disease
2. Age range: 3 years of age and older.
3. NIAID/LIR investigator who has an interest in the patient s illness and is willing to serve as attending physician to supervise the patient's medical care at the NIH.
4. Primary physician outside the NIH
5. The patient or the patient's Legally Authorized Representative is capable of informed consent and signs the consent form. The consent form will be signed by parents or guardians of patients under the age of 18
EXCLUSION CRITERIA:
1. Pregnant.
2. Presence of conditions that, in the judgment of the investigator, may put the participant at undue risk or make them unsuitable for participation in the study.
Citations:
Not Provided
Contacts:
Clinical Trials Number:
NCT00557726